載入中
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
前收盤價
US$4.77
+US$0.02 · +0.42%
盤後
US$4.7506
−US$0.0194 · -0.41%
10月7日 下午7:30 ET
盤中時間採用ET。市場資料可能有所延遲。
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
日內區間
目前US$4.77
52週區間
目前US$4.77
盤中時間採用ET。市場資料可能有所延遲。
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
日內區間
目前US$4.77
52週區間
目前US$4.77
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 3567.6萬 USD | 5950.5萬 USD | 7607.1萬 USD | 3340.1萬 USD | 898萬 USD |
| 銷貨成本 | 4049.7萬 USD | 4700.8萬 USD | 5833.3萬 USD | 2015萬 USD | 655.5萬 USD |
| 毛利 | −482.1萬 USD | 1249.7萬 USD | 1773.8萬 USD | 1325.1萬 USD | 242.5萬 USD |
| 研究與開發 | 23.8萬 USD | 41.8萬 USD | 6.2萬 USD | 38.8萬 USD | 13.2萬 USD |
| 銷售、一般及管理費用 | 120.8萬 USD | 2307.8萬 USD | 2333.5萬 USD | 2877.7萬 USD | 1775.6萬 USD |
| 營業費用 | 474.1萬 USD | 2814.2萬 USD | 6809.2萬 USD | 6047.2萬 USD | 2142.8萬 USD |
| 利息收入 | — | — | — | 2.9萬 USD | — |
| 利息支出 | 19.9萬 USD | 21.3萬 USD | 9.2萬 USD | — | 3.2萬 USD |
| 折舊和攤銷 | 58.2萬 USD | 76.8萬 USD | 233.5萬 USD | 262.9萬 USD | 50.1萬 USD |
| 營業利益 | −956.2萬 USD | −1564.5萬 USD | −5035.4萬 USD | −4722.1萬 USD | −1900.3萬 USD |
| 淨利 | −1.21億 USD | −1590.7萬 USD | −5703.6萬 USD | −5241.5萬 USD | −2124.9萬 USD |
公司資料更新於 2026年10月8日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$185
上漲空間 3778.41%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2025年8月4日 | 1:39 | — | — |
股票分割 | 2023年6月9日 | 1:20 | — | — |
已生效 2025年8月4日
1:39
已生效 2023年6月9日
1:20
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
